Neuropathic pain: Lyzorca is indicated for the treatment of peripheral and central neuropathic pain in adults.
Epilepsy: Lyzorca is indicated as adjunctive therapy in adults with partial seizures with or without secondary generalisation.
Generalised anxiety disorder: Lyzorca is indicated for the treatment of Generalised Anxiety Disorder (GAD) in adults.
Fibromyalgia: Pregabalin is indicated for the management of fibromyalgia.